|
TOP PAPERS published in the last
two-year plus ten-month period
(fifth bimonthly; 2004-October,
2006)
|
 ***Article 1
Total Cites: 130
Article Title: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
Authors: Neoptolemos, JP, Stocken, DD, Friess, H, Bassi, C, Dunn, JA, Hickey, H, Beger, H, Fernandez-cruz, L, Dervenis, C, Lacaine, F, Falconi, M, Pederzoli, P, Pap, A, Spooner, D, Kerr, DJ, Buchler, MW, European Study Grp Pancreatic Can
Journal: NEW ENGL J MED
Volume: 350
Page: 1200-1210
Year: 2004
Addresses:
· Univ Liverpool, Dept Surg, Liverpool, England
· Univ Birmingham, Canc Res UK, Clin Trials Unit, Birmingham, England
· Univ Heidelberg, Heidelberg, Germany
· Univ Verona, Dept Surg, Verona, Italy
· Univ Hosp Surg, Ulm, Germany
· Barcelona Univ Hosp, Barcelona, Spain
· Agia Olga Hosp, Dept Surg, Athens, Greece
· Hop Tenon, Serv Chirurg Digest & Gen, Paris, France
· Mav Hosp, Dept Gastroenterol, Budapest, Hungary
· Queen Elizabeth Hosp, Dept Radiotherapy, Birmingham, England
***Article 2
Total Cites: 103
Article Title: Pancreatic cancer
Authors: Li, DH, Xie, KP, Wolff, R, Abbruzzese, JL
Journal: LANCET
Volume: 363
Page: 1049-1057
Year: 2004
Addresses:
· Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX, USA
· Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, 1515 Holcombe Blvd,Box 426, Houston, TX, USA
***Article 3
Total Cites: 70
Article Title: Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry
Authors: Koopmann, J, Zhang, Z, White, N, Rosenzweig, J, Fedarko, N, Jagannath, S, Canto, MI, Yeo, CJ, Chan, DW, Goggins, M
Journal: CLINICAL CANCER RESEARCH
Volume: 10
Page: 860-868
Year: 2004
Addresses:
· Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD, USA
· Johns Hopkins Med Inst, Dept Med, Baltimore, MD, USA
· Johns Hopkins Med Inst, Dept Surg, Baltimore, MD, USA
· Johns Hopkins Med Inst, Dept Pathol, 632 Ross Bldg,720 Rutland Ave, Baltimore, MD, USA
***Article 4
Total Cites: 63
Article Title: Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: A multicenter phase II trial
Authors: Xiong, HQ, Rosenberg, A, Lobuglio, A, Schmidt, W, Wolff, RA, Deutsch, J, Needle, M, Abbruzzese, JL
Journal: JOURNAL OF CLINICAL ONCOLOGY
Volume: 22
Page: 2610-2616
Year: 2004
Addresses:
· Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Unit 426, Houston, TX, USA
· Greenwich Hosp, Bendheim Canc Ctr, Greenwich, CT, USA
· Univ Alabama, Ctr Comprehens Canc, Clin Studies Unit, Birmingham, AL, USA
· Univ Colorado, Hlth Sci Ctr, Denver, CO, USA
· Trident Palmetto Hematol Oncol Grp, Charleston, SC, USA
· ImClone Syst Inc, Somerville, NJ, USA
***Article 5
Total Cites: 56
Article Title: Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer
Authors: Van Cutsem, E, de Velde, HV, Karasek, P, Oettle, H, Vervenne, WL, Szawlowski, A, Schoffski, P, Post, S, Verslype, C, Neumann, H, Safran, H, Humblet, Y, Ruixo, JP, Ma, Y, Von Hoff, D
Journal: JOURNAL OF CLINICAL ONCOLOGY
Volume: 22
Page: 1430-1438
Year: 2004
Addresses:
· Univ Hosp Gasthuisberg, Dept Internal Med, Louvain, Belgium
· St Luc Univ Hosp, Brussels, Belgium
· Masarykuv Oncol, Brno, Czech Republic
· Hannover Med Sch, Hannover, Germany
· Mannheim Univ Hosp, Mannheim, Germany
· Acad Med Ctr, Amsterdam, Netherlands
· Ctr Canc, Warsaw, Poland
· Brown Univ, Providence, RI, USA
· Johnson & Johnson Pharmaceut, Res & Dev, Beerse, Belgium
· Johnson & Johnson Pharmaceut, Res & Dev, Titusville, NJ, USA
· Arizona Canc Ctr, Tucson, AZ, USA
· Univ Hosp Gasthuisberg, Dept Internal Med, Herestraat 49, Louvain, Belgium
***Article 6
Total Cites: 43
Article Title: Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients
Authors: Thomas, AM, Santarsiero, LM, Lutz, ER, Armstrong, TD, Chen, YC, Huang, LQ, Laheru, DA, Goggins, M, Hruban, RH, Jaffee, EM
Journal: JOURNAL OF EXPERIMENTAL MEDICINE
Volume: 200
Page: 297-306
Year: 2004
Addresses:
· Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Dept Oncol, Baltimore, MD, USA
· Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Grad Program Immunol, Baltimore, MD, USA
· Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Dept Pathol, Baltimore, MD, USA
· Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Dept Oncol, Bunting Blaustein Canc Res Bldg,Rm 4M07,1650 Orle, Baltimore, MD, USA
***Article 7
Total Cites: 40
Article Title: Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection
Authors: Nakamura, T, Furukawa, Y, Nakagawa, H, Tsunoda, T, Ohigashi, H, Murata, K, Ishikawa, O, Ohgaki, K, Kashimura, N, Miyamoto, M, Hirano, S, Kondo, S, Katoh, H, Nakamura, Y, Katagiri, T
Journal: ONCOGENE
Volume: 23
Page: 2385-2400
Year: 2004
Addresses:
· Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med,Minato Ku, Tokyo, Japan
· Hokkaido Univ, Grad Sch Med, Div Canc Med, Kita Ku, Sapporo, Japan
· RIKEN, Inst Phys & Chem Res,SNP Res Ctr, Lab Med Informat, Tsurumi Ku, Yokohama, Japan
· Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Higashinari Ku, Osaka, Japan
· Kyoto Police Hosp, Dept Surg, Kita Ku, Kyoto, Japan
· Teine Keijinkai Hosp, Dept Surg, Teine Ku, Sapporo, Japan
***Article 8
Total Cites: 40
Article Title: Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer
Authors: Rinehart, J, Adjei, AA, Lorusso, PM, Waterhouse, D, Hecht, JR, Natale, RB, Hamid, O, Varterasian, M, Asbury, P, Kaldjian, EP, Gulyas, S, Mitchell, DY, Herrera, R, Sebolt-leopold, JS, Meyer, MB
Journal: JOURNAL OF CLINICAL ONCOLOGY
Volume: 22
Page: 4456-4462
Year: 2004
Addresses:
· Univ Alabama, Wallace Tumor Inst 263, Birmingham, AL, USA
· Mayo Clin, Rochester, MN, USA
· Wayne State Univ, Karmanos Canc Inst, Detroit, MI, USA
· Oncol Hematol Care Inc, Cincinnati, OH, USA
· Univ Calif Los Angeles, Med Ctr, Los Angeles, CA, USA
· Cedars Sinai Med Ctr, Los Angeles, CA, USA
· Univ Alabama, Wallace Tumor Inst 263, 1824 6th Ave S, Birmingham, AL, USA
***Article 9
Total Cites: 38
Article Title: Main-duct intraductal papillary mucinous neoplasms of the pancreas - Clinical predictors of malignancy and long-term survival following resection
Authors: Salvia, R, Fernandez-del Castillo, C, Bassi, C, Thaver, SP, Falconi, M, Mantovani, W, Pederzoli, P, Warshaw, AL
Journal: ANNALS OF SURGERY
Volume: 239
Page: 678-685
Year: 2004
Addresses:
· Massachusetts Gen Hosp, Dept Surg, Boston, MA, USA
· Univ Verona, Dept Surg, Verona, Italy
· Univ Verona, Dept Publ Hlth & Med, Verona, Italy
· Massachusetts Gen Hosp, Dept Surg, ACC 36, Boston, MA, USA
***Article 10
Total Cites: 34
Article Title: Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate
Authors: Lima, CMR, Green, MR, Rotche, R, Miller, WH, Jeffrey, GM, Cisar, LA, Morganti, A, Orlando, N, Gruia, G, Miller, LL
Journal: JOURNAL OF CLINICAL ONCOLOGY
Volume: 22
Page: 3776-3783
Year: 2004
Addresses:
· Univ Miami, Miami, FL, USA
· Sylvester Canc Ctr, Miami, FL, USA
· Med Univ S Carolina, Charleston, SC, USA
· US Oncol, Dallas, TX, USA
· Pfizer Corp, New York, NY, USA
· Jewish Gen Hosp, Montreal, Canada
· Christchurch Hosp, Christchurch, New Zealand
· Pharmacia Italy SPA, Pfizer Grp, Nerviano, Italy
· Univ Miami, 1475 NW 12th Ave,Suite 3310, Miami, FL, USA
***Article 11
Total Cites: 33
Article Title: Curative resection is the single most important factor determing outcome in patients with pancreatic adenocarcinoma
Authors: Wagner, M, Redaelli, C, Lietz, M, Seiler, CA, Friess, H, Buchler, MW
Journal: BRITISH JOURNAL OF SURGERY
Volume: 91
Page: 586-594
Year: 2004
Addresses:
· Univ Bern, Dept Visceral & Transplantat Surg, Bern, Switzerland
· Univ Heidelberg, Dept Gen Surg, Neuenheimer Feld 110, Heidelberg, Germany
***Article 12
Total Cites: 32
Article Title: A prospective study of aspirin use and the risk of pancreatic cancer in women
Authors: Schernhammer, ES, Kang, JH, Chan, AT, Michaud, DS, Skinner, HG, Giovannucci, E, Colditz, GA, Fuchs, CS
Journal: J NATL CANCER I
Volume: 96
Page: 22-28
Year: 2004
Addresses:
· Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA, USA
· Harvard Univ, Sch Med, Boston, MA, USA
· KFJ Spital, Ludwig Boltzmann Inst Appl Canc Res, Vienna, Austria
· Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA, USA
· NCI, Nutr Epidemiol Branch, Rockville, MD, USA
· Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA, USA
· Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA, USA
· Harvard Univ, Ctr Canc Prevent, Boston, MA, USA
· Dana Farber Canc Inst, Program Epidemiol, Boston, MA, USA
· Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA, USA
· Brigham & Womens Hosp, Channing Lab, Dept Med, 181 Longwood Ave, Boston, MA, USA
***Article 13
Total Cites: 31
Article Title: Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: Results of a GERCOR and GISCAD phase III trial
Authors: Louvet, C, Labianca, R, Hammel, P, Lledo, G, Zampino, MG, Andre, T, Zaniboni, A, Ducreux, M, Aitini, E, Taieb, J, Faroux, R, Lepere, C, de Gramont, A
Journal: JOURNAL OF CLINICAL ONCOLOGY
Volume: 23
Page: 3509-3516
Year: 2005
Addresses:
· Hop St Antoine, Serv Oncol, Paris, France
· Hop Tenon, Paris, France
· Hop La Pitie Salpetriere, Paris, France
· Hop Beaujon, Clichy, France
· Clin St Jean, Lyon, France
· Inst Gustave Roussy, Villejuif, France
· Hop Ambroise Pare, Boulogne, France
· Azienda Osped C Poma, Mantova, Italy
· Ist Europeo Oncol, Milan, Italy
· Casa Cura Poliambulanza, Brescia, Italy
· Osped Riuniti Bergamo, Bergamo, Italy
· Hop St Antoine, Serv Oncol, 184 Rie Faubourg St Antoine, Paris, France
***Article 14
Total Cites: 30
Article Title: High-resolution characterization of the pancreatic adenocarcinoma genome
Authors: Aguirre, AJ, Brennan, C, Bailey, G, Sinha, R, Feng, B, Leo, C, Zhang, YY, Zhang, J, Gans, JD, Bardeesy, N, Cauwels, C, Cordon-cardo, C, Redston, MS, Depinho, RA, Chin, L
Journal: P NATL ACAD SCI USA
Volume: 101
Page: 9067-9072
Year: 2004
Addresses:
· Dana Farber Canc Inst, Dept Med Oncol, Boston, MA, USA
· Brigham & Womens Hosp, Dept Pathol, Boston, MA, USA
· Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY, USA
· Brigham & Womens Hosp, Dept Dermatol, Boston, MA, USA
· Harvard Univ, Sch Med, Boston, MA, USA
***Article 15
Total Cites: 30
Article Title: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells
Authors: Duxbury, MS, Ito, H, Zinner, MJ, Ashley, SW, Whang, EE
Journal: ONCOGENE
Volume: 23
Page: 465-473
Year: 2004
Addresses:
· Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg, Boston, MA, USA
***Article 16
Total Cites: 29
Article Title: Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity
Authors: Wei, DY, Wang, LW, He, YJ, Xiong, HQ, Abbruzzese, JL, Xie, KP
Journal: CANCER RESEARCH
Volume: 64
Page: 2030-2038
Year: 2004
Addresses:
· Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX, USA
· Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX, USA
· Univ Texas, Grad Sch Biomed Sci, Program Canc Biol, Houston, TX, USA
· Univ Texas, MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Unit 426,1515 Holcombe Blvd, Houston, TX, USA
***Article 17
Total Cites: 28
Article Title: Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes
Authors: Holzmann, K, Kohlhammer, H, Schwaenen, C, Wessendorf, S, Kestler, HA, Schwoerer, A, Rau, B, Radlwimmer, B, Dohner, H, Lichter, P, Gress, T, Bentz, M
Journal: CANCER RESEARCH
Volume: 64
Page: 4428-4433
Year: 2004
Addresses:
· Univ Ulm, IZKF, Chip Facil, Ulm, Germany
· Univ Ulm, Innere Med Abt 1, Ulm, Germany
· Univ Ulm, Abt Innere Med 3, Ulm, Germany
· Univ Ulm, Forsch Dozentur Bioinformat, Ulm, Germany
· Univ Saarlandes Kliniken, Abt Allgemeine Visceral & Gefasschirurg, Homburg, Germany
· Deutsch Krebsforschungszentrum, Abt Mol Genet, Heidelberg, Germany
· Univ Ulm, IZKF, Chip Facil, Helmholtzstr 8-1, Ulm, Germany
***Article 18
Total Cites: 28
Article Title: CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer
Authors: Mori, T, Doi, R, Koizumi, M, Toyoda, E, Ito, D, Kami, K, Masui, T, Fujimoto, K, Tamamura, H, Hiramatsu, K, Fujii, N, Imamura, M
Journal: MOLECULAR CANCER THERAPEUTICS
Volume: 3
Page: 29-37
Year: 2004
Addresses:
· Kyoto Univ, Dept Surg & Surg Basic Sci, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto, Japan
· Kyoto Univ, Dept Bioorgan Med Chem, Grad Sch Pharmaceut Sci, Kyoto, Japan
***Article 19
Total Cites: 27
Article Title: EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma
Authors: Duxbury, MS, Ito, H, Zinner, MJ, Ashley, SW, Whang, EE
Journal: ONCOGENE
Volume: 23
Page: 1448-1456
Year: 2004
Addresses:
· Harvard Univ, Brigham & Womens Hosp, Dept Surg, Sch Med, Boston, MA, USA
***Article 20
Total Cites: 26
Article Title: Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions
Authors: Ohuchida, K, Mizumoto, K, Murakami, M, Qian, LW, Sato, N, Nagai, E, Matsumoto, K, Nakamura, T, Tanaka, M
Journal: CANCER RESEARCH
Volume: 64
Page: 3215-3222
Year: 2004
Addresses:
· Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Higashi Ku, Fukuoka, Japan
· Osaka Univ, Grad Sch Med Sci, Coursee Adv Med, Div Mol Regenerat Med, Suita, Japan
|
|
|
